步长稳心颗粒治疗更年期综合症46例
 |
| 第1页 |
参见附件(1260KB，1页)。
【摘要】目的 对步长稳心颗粒对治疗更年期综合症的疗效及安全性进行观察。方法 选择、我院2008年6月—2010年6月应于步长稳心颗粒治疗与更年期综合征患者46例女性患者：年龄45—55岁之间，随机分为两组：A组为步长稳心颗粒治疗组，B组为谷维素、阿替洛尔、多维元素片治疗组。A组共入选46例，B组共入选46例，结果 A组46例更年期综合症患者中治疗2个月，治疗的总有效率为81.58%；B组46例更年期综合症患者中治疗2个月，治疗的总有效率为82.82%，两组总效率比较差异无统计学意义(P>0.05)，A组的副作用发生率为10.52%，而B组的副作用发生率为21.21%，两组副作用发生率比较差异有统计学意义(P<0.05)；结论 对更年期综合症，步长稳心颗粒具有较为理想的治疗效果，副作用的发生率明显低于谷维素、阿替洛尔，且未发现不能耐受或严重的副作用。经临床应用，稳心颗粒无明显的不良反应，无诱发心肌缺血及心律失常的证据，口服安全有效，为中医药治疗心律失常开辟了一新的途径。
【关键词】步长稳心颗粒 谷维素、阿替洛尔、多维元素 更年期综合症
中图分类号：R259 文献标识码：A 文章编号：1005-0515(2011)8-003-01
BUchangwenxin treatment of menopausal syndrome, 46 cases of granular
Hetian Prefecture, Xinjiang People's HospitalA Dalaiti·A Bulizi
【Abstract】Objective To Buchangwenxin particles on the treatment of menopausal syndrome, the efficacy and safety of observation. Methods hospital in June 2008 - June 2010 should step Wenxinkeli treatment of 46 patients with menopausal syndrome female patients: age 45-55 years old, were randomly divided into two groups: A group To step Wenxinkeli treatment group, B group oryzanol, atenolol, multi-dimensional elements in treatment group. A group of selected 46 cases, B group of selected 46 patients, the Results A group of 46 patients in the treatment of menopausal syndrome patients 2 months of treatment the total effective rate was 81.58%; B group of 46 patients in the treatment of menopausal syndrome 2 months of treatment, the total effective rate was 82.82 percent, the overall efficiency of the two groups no statistically significant difference(P> 0.05), A group of side effects was 10.52%, while the incidence of side effects in group B 21.21%, two group differences in the incidence of side effects was statistically significant (P<0.05); Conclusion menopausal syndrome, Buchangwenxin particles have an ideal treatment, side effects were significantly lower than oryzanol, atenolol and did not find or can not tolerate serious side effects. The clinical application of Wenxinkeli no significant adverse reactions, non-induced evidence of myocardial ischemia and arrhythmia, oral safe and effective for the treatment of arrhythmia in medicine opens a new way.
【Keywords】Buchangwenxin particles oryzanol, atenolol, multi-dimensional elements menopausal syndrome
我院2008年6月—2010年6月应于步长稳心颗粒治疗与更年期综合征患者46例，取得了较好疗效，并与应用西药(谷维素、阿替洛尔、多维元素片)治疗的46例进行对照观察，现报道如下：
1 临床资料
选择我院2008年6月—2010年6月有不同程度的更年期综合症状的门诊与住院女患者，并经妇检、B超、心电图、内分泌，甲状腺功能测定等相关检查，排除器质性病变，确诊为更年期综合征者92例，年龄45—55岁，平均年龄49.5岁，随机分为2组，治疗组46例和对照组46例。
2 治疗方法
治疗组给予步长稳定颗粒，起始量为15g/d ......
您现在查看是摘要介绍页，详见PDF附件(1260KB，1页)。